Outcomes

No. = 49 (%)

Partial response

14 (35)

Stable disease

16 (40)

Progressive disease

10 (25)

Not evaluable

9

Painful hepatomegaly:

Responders (21/30)

21 (70)

Non-responders (9/30)

9 (30)

P value

0.03

Median overall survival, 95% CI

7.0 (2.63 - 11.36)

Median progression-free survival, 95% CI

4.0 (2.51 - 5.48)